retatrutide trial duration Eli Lilly infiltrates anti-obesity market as Phase III for begins Retatrutide vs Ozempic: Clinical Trial

What Is GLP-1 and Why Does It Matter for Appetite Control GLP-1 (glucagon-like peptide-1) is a gut hormone released after eating

In February 2026, the FDA released a report alerting patients and providers about the risks of compounded GLP-1 medications

These flavor-packed options represent convenience, comfort, and cultural connection that generic diets would eliminate completely

If you want to compare this with broader GLP-1 storage guidance, review these GLP-1 expiration facts

This should raise a red flag. Living up to the hype While experts caution against overusing GLP-1RAs or viewing them as a universal cure-all for obesity, physicians and researchers agree that the drugs are highly effective for weight management and Type 2 diabetes treatment

What about Ozempic face can microdosing prevent it